BIOLASE, Inc.
BIOLQ
$0.0075
-$0.0014-15.73%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 10.85M | 11.56M | 10.13M | 13.49M | 10.92M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.85M | 11.56M | 10.13M | 13.49M | 10.92M |
| Cost of Revenue | 6.47M | 6.95M | 6.80M | 9.97M | 7.18M |
| Gross Profit | 4.38M | 4.61M | 3.34M | 3.52M | 3.75M |
| SG&A Expenses | 4.16M | 6.76M | 6.58M | 6.95M | 6.08M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.55M | 14.78M | 14.66M | 18.57M | 14.62M |
| Operating Income | -695.00K | -3.22M | -4.53M | -5.08M | -3.70M |
| Income Before Tax | -1.42M | -2.78M | -6.47M | -5.34M | -4.57M |
| Income Tax Expenses | 12.00K | 20.00K | 19.00K | -15.00K | 15.00K |
| Earnings from Continuing Operations | -1.43M | -2.80M | -6.49M | -5.33M | -4.59M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.43M | -2.80M | -6.49M | -5.33M | -4.59M |
| EBIT | -695.00K | -3.22M | -4.53M | -5.08M | -3.70M |
| EBITDA | -50.00K | -2.57M | -3.87M | -4.41M | -3.14M |
| EPS Basic | -0.04 | -0.08 | -0.36 | -7.36 | -10.35 |
| Normalized Basic EPS | -0.02 | -0.05 | -0.23 | -1.10 | -2.42 |
| EPS Diluted | -0.04 | -0.08 | -0.36 | -7.36 | -10.35 |
| Normalized Diluted EPS | -0.02 | -0.05 | -0.23 | -1.10 | -2.42 |
| Average Basic Shares Outstanding | 36.08M | 33.39M | 17.84M | 3.03M | 1.18M |
| Average Diluted Shares Outstanding | 36.08M | 33.39M | 17.84M | 3.03M | 1.18M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
